Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
ORMP

Oramed

$2.43

-0.06 (-2.41%)

08:28
11/21/19
11/21
08:28
11/21/19
08:28
Hot Stocks
Oramed patent granted in Japan for protease inhibitor »

Oramed's Japanese…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORMP

Oramed

$2.62

0.16 (6.50%)

05:33
11/18/19
11/18
05:33
11/18/19
05:33
Conference/Events
Oramed to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

ORMP

Oramed

$2.93

-0.085 (-2.82%)

07:28
11/12/19
11/12
07:28
11/12/19
07:28
Conference/Events
Oramed to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

ORMP

Oramed

$2.93

-0.085 (-2.82%)

07:17
11/12/19
11/12
07:17
11/12/19
07:17
Hot Stocks
Oramed announces results from Phase IIb trial evaluating ORMD-0801 »

Oramed Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a month ago
ORMP

Oramed

$3.05

-0.005 (-0.16%)

08:42
09/17/19
09/17
08:42
09/17/19
08:42
Hot Stocks
Oramed announces last patient treated in Phase IIb HbA1c trial of ORMD-0801 »

Oramed Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORMP

Oramed

$2.92

0.05 (1.74%)

06:49
09/11/19
09/11
06:49
09/11/19
06:49
Initiation
Oramed initiated at Ladenburg »

Oramed initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a quarter ago
KALV

KalVista

$18.33

0.78 (4.44%)

, SNES

SenesTech

$1.35

(0.00%)

13:37
07/22/19
07/22
13:37
07/22/19
13:37
On The Fly
Fly Insider: KalVista, Calavo Growers among week's notable insider transactions »

Welcome to "Fly Insider,"…

KALV

KalVista

$18.33

0.78 (4.44%)

SNES

SenesTech

$1.35

(0.00%)

INUV

Inuvo

$0.30

-0.0062 (-2.03%)

ONCS

OncoSec

$2.44

-0.04 (-1.61%)

ORMP

Oramed

$3.75

-0.15 (-3.85%)

SHAK

Shake Shack

$74.75

0.575 (0.78%)

CVGW

Calavo Growers

$91.49

0.6 (0.66%)

DAL

Delta Air Lines

$61.56

0.65 (1.07%)

FLDM

Fluidigm

$11.57

0.09 (0.78%)

ACN

Accenture

$195.32

1.37 (0.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

  • 05

    Aug

  • 05

    Aug

  • 12

    Aug

  • 14

    Aug

  • 22

    Aug

  • 09

    Sep

  • 26

    Sep

ORMP

Oramed

$3.27

(0.00%)

14:49
07/11/19
07/11
14:49
07/11/19
14:49
Options
Oramed options imply 0.0% move in share price post-earnings, below median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORMP

Oramed

$3.06

0.01 (0.33%)

08:56
05/21/19
05/21
08:56
05/21/19
08:56
Hot Stocks
Oramed completes enrollement for Phase IIb clinical study of its insulin capsule »

Oramed Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORMP

Oramed

$3.46

-0.03 (-0.86%)

08:56
04/04/19
04/04
08:56
04/04/19
08:56
Hot Stocks
Oramed granted U.S. patent for oral exenatide »

Oramed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.